2013
DOI: 10.1111/sji.12061
|View full text |Cite
|
Sign up to set email alerts
|

Atrial Fibrillation: Inflammation in Disguise?

Abstract: Atrial fibrillation is highly prevalent, and affected patients are at an increased risk of a number of complications, including heart failure and thromboembolism. Over the past years, there has been increasing interest in the role of inflammatory processes in atrial fibrillation, from the first occurrence of the arrhythmia to dreaded complications such as strokes or peripheral emboli. As the standard drug combination which aims at rate control and anticoagulation only offers partial protection against complica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 112 publications
0
11
0
Order By: Relevance
“…29 Finally, AF might additionally impact stroke severity and thus post-stroke outcome via concomitant or resultant endothelial dysfunction, oxidative stress, and inflammation. 4,20,30 …”
Section: Discussionmentioning
confidence: 99%
“…29 Finally, AF might additionally impact stroke severity and thus post-stroke outcome via concomitant or resultant endothelial dysfunction, oxidative stress, and inflammation. 4,20,30 …”
Section: Discussionmentioning
confidence: 99%
“…It is established that atrial fibrillation is associated with increased inflammatory activity, reviewed in (Lappegård et al, 2013), and also that inflammation is a key player in the development of thrombo-embolic complications (Hijazi et al, 2013). Paradoxically, due to increased survival in coronary heart disease and congestive heart failure, along with an ageing population, the prevalence of atrial fibrillation is increasing.…”
Section: Arrhythmias and The Complement Systemmentioning
confidence: 99%
“…22,23 Ischemic stroke is followed by a shortlasting inflammatory response in which cytokines (i.e., IL-1 receptor antagonist and IL-6), adhesion molecules (i.e., intercellular adhesion molecule-1 and E/P-selectins), and some chemokines (i.e., CXCL16) are released to the bloodstream in the acute phase. 27 Based on this evidence, inflammatory mediators whose plasma concentrations are increased in the acute phase of ischemic stroke may affect the intrinsic system, leading to focal firing and subsequent development of AF in acute stroke patients. 26 Of note, AF and acute ischemic stroke share some of these inflammatory markers, since IL-6, IL-1, TNFa, and CRP have been implicated in the genesis of AF as well.…”
mentioning
confidence: 99%